Manufacturing

Editor of Pharmaceutical Technology Europe

Articles

Shifting toward more technological solutions and ensuring a greater understanding of the workforce’s needs will give both CROs and sponsors a market advantage.

CROs Gaining a Competitive Edge

Aragen’s new 12,000 ft² facility will include various dosage form capabilities, including oral solids, liquids, topicals, and films.

Aragen to Invest in New Formulation Manufacturing Facility in Hyderabad, India

Catalent has announced a $175 million project to expand its manufacturing facility for large scale oral dose forms at its Winchester, Ky, site.

Catalent Invests $175 Million to Expand Manufacturing Capabilities and Capacity in US Facility

Catalent has announced the completion of a $30 million project at its facility in Limoges, France focused on biopharmaceutical development and drug product manufacturing. 

Catalent Completes $30 Million Project for Biopharmaceutical Development and Manufacturing in Limoges, France

Jessica Baseggio is research laboratory analysts at SG Lab Analytics, Stevanato Group.

Chiara Callegari is research laboratory analysts at SG Lab Analytics, Stevanato Group.

Enrico Barichello is SG Alba Platform product manager, Stevanato Group, 

A coating technology for a staked needle prefillable syringe reduces the potential risks associated with silicone oil as a lubricant.

Considering a Coating Technology as an Alternative to Silicone Oil

Researchers in China report test results for a microneedle patch for COVID-19 vaccine delivery.

Researchers Cite Positive Results in COVID-19 Microneedle Patch Trial

Lilly’s insulin, lyumjev, receives FDA approval for an expanded label.

FDA Approves Expanded Label for Lilly’s Lyumjev

ImmunityBio will proceed with a Phase I/II/III trial in South Africa of their dual-antigen T-cell vaccine as a boost in participants who were previously vaccinated against COVID-19.

SAHPRA Authorizes ImmunityBio to Proceed with Trial of T-Cell Vaccine as Booster Against COVID-19

Lonza further expands its micronization services with the acquisition of Swiss contract manufacturer, Micro-Macinazione, following its previous $5.5-billion acquisition of dosage form provider, Capsugel.

Lonza Boosts Micronization Capacity with Acquisition

The initiative targets countries with less developed and evolving healthcare systems such as Latin America, South East Asia, and Africa.

Manufacturing, Specialty Dosage Forms